PUTAO CEN: Open Payments
NPI 1891947735 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146,574 in 101 payments from 13 companies in 2025. Trend: 2023 $145,897 · 2024 $128,897 · 2025 $146,574
Speaker / faculty: $102,828Speaker / faculty: $27,650Travel & lodging: $8,047Consulting: $5,555Food & beverage: $2,494
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 30 | $50,963 |
| TAIHO ONCOLOGY, INC. | 22 | $43,998 |
| Eisai Inc. | 19 | $32,716 |
| Merck Sharp & Dohme LLC | 8 | $12,795 |
| Ipsen Biopharmaceuticals, Inc | 2 | $2,891 |
| AstraZeneca Pharmaceuticals LP | 5 | $2,550 |
| Tempus AI, Inc | 3 | $201 |
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| Immunocore Limited | 1 | $121 |
| PFIZER INC. | 4 | $90 |
Products named: LONSURF, Vyloy, Lenvima, Padcev, KEYTRUDA, WELIREG, Onivyde, IMFINZI.
Industry payments across TX — which companies pay providers there.
